Jagsonpal Pharmaceuticals shareholding pattern

JAGSNPHARM

HealthcareSmall

251

5.90 (2.41%)
Last updated on 18 Aug, 2025 | 15:51 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Jagsonpal Pharmaceuticals Shareholding Pattern

  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2024-25
  • 2025-26
  • 2023-24
Total Promoters
Segment
Percent

Total Promoters

67.81%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

2.1%

Domestic Institutional Investors

0%

Retail

30.08%

Others

0.01%

Total Promoters
MAR '24
68.09%
JUN '24
68.04%
SEP '24
67.97%
DEC '24
67.81%

Jagsonpal Pharmaceuticals FAQs

As of 08-2025, the promoter shareholding in Jagsonpal Pharmaceuticals stands at 67.65% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Jagsonpal Pharmaceuticals is 2.17% and 0.06% respectively.

The retail shareholding of the Jagsonpal Pharmaceuticals is 30.12%.

Changes in shareholding patterns of Jagsonpal Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Jagsonpal Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.